Education
About Us
Working with TipRanks
Follow Us
Agilent (A)
NYSE:A
A Stock Chart & Stats
Day’s Range― - ―
52-Week Range$96.43 - $155.35
Previous CloseN/A
Volume231.77K
Average Volume (3M)2.56M
Market Cap
$29.28B
Enterprise Value$39.64B
Total Cash (Recent Filing)$2.65B
Total Debt (Recent Filing)$3.69B
Price to Earnings (P/E)23.6
Beta1.01
Next Earnings
May 27, 2025EPS Estimate
1.27Last Dividend Ex-Date
Apr 01, 2025Dividend Yield0.9%
Share Statistics
EPS (TTM)1.31
Shares Outstanding285,102,720
10 Day Avg. Volume3,404,339
30 Day Avg. Volume2,563,628
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.27
Price to Cash Flow (P/CF)20.00
P/FCF Ratio18.90
Enterprise Value/Market Cap1.35
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit11.21
Enterprise Value/Ebitda22.80
Forecast
1Y Price Target
$135.40Price Target Upside27.40% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAgilent reported F1Q25 sales just above the high end of their guide range, showing strong performance.
Market PositionAgilent won over 50% of China stimulus-related tenders, enhancing their market position in China.
Product DevelopmentInfinity III sales reached $100M, highlighting the early stages of upgrade cycle demand as thousands of Agilent 1100s are reaching end-of-support status.
Bears Say
Currency ImpactAgilent's revenue guidance for FY25 was lowered due to incremental FX headwinds.
Market ChallengesThe Applied Markets Group segment saw a decline of 2%, indicating a challenge in that area.
Market VisibilityAgilent's valuation appears fair given higher China exposure and limited visibility into market rebound, leading to a Neutral rating.
---
Ownership Overview
0.26% Insiders
28.46% Mutual Funds
0.44% Other Institutional Investors
45.04% Public Companies and
Individual Investors
A FAQ
What was Agilent’s price range in the past 12 months?
Agilent lowest stock price was $96.43 and its highest was $155.35 in the past 12 months.
What is Agilent’s market cap?
Agilent’s market cap is $29.28B.
When is Agilent’s upcoming earnings report date?
Agilent’s upcoming earnings report date is May 27, 2025 which is in 28 days.
How were Agilent’s earnings last quarter?
Agilent released its earnings results on Feb 26, 2025. The company reported $1.31 earnings per share for the quarter, beating the consensus estimate of $1.281 by $0.029.
Is Agilent overvalued?
According to Wall Street analysts Agilent’s price is currently Undervalued.
Does Agilent pay dividends?
Agilent pays a Quarterly dividend of $0.247 which represents an annual dividend yield of 0.9%. See more information on Agilent dividends here
What is Agilent’s EPS estimate?
Agilent’s EPS estimate is 1.27.
How many shares outstanding does Agilent have?
Agilent has 285,102,720 shares outstanding.
What happened to Agilent’s price movement after its last earnings report?
Agilent reported an EPS of $1.31 in its last earnings report, beating expectations of $1.281. Following the earnings report the stock price went down -5.493%.
Which hedge fund is a major shareholder of Agilent?
Currently, no hedge funds are holding shares in A
---
Agilent Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$135.40 (27.40% Upside)
$135.40 (27.40% Upside)
Blogger Sentiment
Bullish
A Sentiment 81%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.6M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 0.5%
Last 30 Days ▲ 1.6%
Last 30 Days ▲ 1.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.63%
12-Months-Change
Fundamentals
Return on Equity
20.61%
Trailing 12-Months
Asset Growth
8.82%
Trailing 12-Months
Company Description
Agilent
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
---
A Company Deck
---
A Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Agilent's earnings call highlighted a strong start to the fiscal year with notable achievements in revenue growth, digital transformation, and success in China stimulus awards. However, challenges were noted in the Academia and Government markets, currency impacts, and potential U.S. federal funding uncertainties.Read More>---
A Revenue Breakdown
49.39% Life Sciences and Applied Markets
25.36% Diagnostics and genomics
25.25% Agilent CrossLab
---
A Stock 12 Month Forecast
Average Price Target
$135.40
▲(27.40% Upside)
Technical Analysis
---